London Calling 2025 - Speakers
Speakers
Check out the line up of speakers at London Calling 2025.
Oxford Nanopore Technologies
Dr. Janessa Laskin
- Job title
- Institution
- BC Cancer Centre & University of British Columbia, Canada
- Biography
Dr. Laskin is a Clinical Associate Professor in the Department of Medicine at The University of British Columbia, Canada. She is also an Associate Member in Canada’s Michael Smith Genome Sciences Centre, and a Medical Oncologist at BC Cancer, in Vancouver. Dr. Laskin’s research is focused on genomic and personalized medicine as the clinical program leader for the Personalized Oncogenomics (POG) Program. POG is a collaborative translational research effort that uses in-depth genomic sequencing to guide chemotherapy decision-making in a clinically relevant timeframe.
- Recent publications
Pleasance E. et al. Whole-genome and transcriptome analysis enhances precision cancer treatment options. Ann Oncol. 33(9):939–949 (2022). DOI: 10.1016/j.annonc.2022.05.522
Pleasance E. et al. Pan-cancer analysis of advanced patient tumors reveals interactions between therapy and genomic landscapes. Nat Cancer. 1:452–468 (2020). DOI: 10.1038/s43018-020-0050-6
Oxford Nanopore Technologies products are RUO. Products labelled/branded as Oxford Nanopore Diagnostics may be RUO or may be regulated as in-vitro diagnostic devices in some jurisdictions, please check individual product labelling. Oxford Nanopore Technologies present the materials of third parties within the user community acknowledging that those materials belong to and are the true statements and representations of those third parties. Oxford Nanopore Technologies make no endorsements of the materials shown and the statements made.
